Subcutaneous Injection of Botulinum Toxin A Is Beneficial in Postherpetic Neuralgia
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To assess the benefits of subcutaneous injection of botulinum toxin A (BTX-A) for the treatment of postherpetic neuralgia (PHN). DESIGN: We investigated the therapeutic benefits of BTX-A in subjects with PHN in a randomized, double-blind, placebo-controlled study. Sixty subjects with PHN were randomly and evenly distributed into BTX-A, lidocaine, and placebo groups. MEASURES: After randomization, one of the following solutions was injected subcutaneously in the affected dermatome: 5u/mL BTX-A, 0.5% lidocaine, or 0.9% saline (placebo). Visual analog scale (VAS) pain and sleeping time (hours) were evaluated at the time of pretreatment, day 1, day 7, and 3 months posttreatment. Opioid usage was calculated at day 7 and 3 months posttreatment. RESULTS: Compared with pretreatment, VAS pain scores decreased at day 7 and 3 months posttreatment in all three groups (P<0.01). However, the VAS pain scores of the BTX-A group decreased more significantly compared with lidocaine and placebo groups at day 7 and 3 months posttreatment (P<0.01). Sleep time (hours) had improved at day 7 and at 3 months compared with pretreatment in all three groups, but the BTX-A group improved more significantly compared with lidocaine and placebo groups (P<0.01). The percent of subjects using opioids posttreatment in the BTX-A group was the lowest (21.1%) compared with the lidocaine (52.6%) and placebo (66.7%) groups (P<0.01). CONCLUSIONS: Subcutaneous administration of BTX-A significantly decreased pain in PHN and reduced opioid use compared with lidocaine and placebo at day 7 and 3 months post-treatment. It also increased subjects' sleep times.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pharmacologic management of neuropathic pain: Evidence-based recommendations
Dworkin, R. H., O’Connor, A. B., Backonja, M., Farrar, J. T., Finnerup, N. B., Jensen, T. S., Kalso, E. A., Loeser, J. D., Miaskowski, C., Nurmikko, T. J., et al. (2007) · Pain · doi:10.1016/j.pain.2007.08.033 · Cited by 2,126
Algorithm for neuropathic pain treatment: An evidence based proposal
Finnerup, N. B., Otto, M., McQuay, H. J., Jensen, T. S., & Sindrup, S. H. (2005) · Pain · doi:10.1016/j.pain.2005.08.013 · Cited by 1,330
EFNS guidelines on pharmacological treatment of neuropathic pain
Attal, N., Cruccu, G., Haanpää, M., Hansson, P., Jensen, T. S., Nurmikko, T., Sampaio, C., Sindrup, S., & Wiffen, P. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01511.x · Cited by 880
Yawn, B. P., Saddier, P., Wollan, P. C., Sauver, J. L. S., Kurland, M. J., & Sy, L. S. (2007) · Mayo Clinic Proceedings · doi:10.4065/82.11.1341 · Cited by 867
Subcutaneous administration of botulinum toxin A reduces formalin-induced pain
Cui, M., Khanijou, S., Rubino, J., & Aoki, K. R. (2004) · Pain · doi:10.1016/j.pain.2003.10.008 · Cited by 676
Brashear, A., Gordon, M. F., Elovic, E. P., Kassicieh, V. D., Marciniak, C. M., Do, M., Lee, C.-H., JENKINS, S. W., & Turkel, C. C. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011892 · Cited by 603
Botulinum Toxin Type A as a Migraine Preventive Treatment
Silberstein, S., Mathew, N., Saper, J., Jenkins, S., & for the BOTOX Migraine Clinical Research Group (2000) · Headache: The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.2000.00066.x · Cited by 541
Botulinum toxin type a induces direct analgesic effects in chronic neuropathic pain
Ranoux, D., Attal, N., Morain, F., & Bouhassira, D. (2008) · Annals of Neurology · doi:10.1002/ana.21427 · Cited by 459
Long-Distance Retrograde Effects of Botulinum Neurotoxin A
Antonucci, F., Rossi, C., Gianfranceschi, L., Rossetto, O., & Caleo, M. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0375-08.2008 · Cited by 450
McMahon, H. T., Foran, P., Dolly, J. O., Verhage, M., Wiegant, V. M., & Nicholls, D. G. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36614-1 · Cited by 298
Cited by
Mechanisms of Botulinum Toxin Type A Action on Pain
Matak, I., Bölcskei, K., Bach-Rojecky, L., & Helyes, Z. (2019) · Toxins · doi:10.3390/toxins11080459 · Cited by 267
Subcutaneous Botulinum Toxin for Chronic Post‐Thoracotomy Pain
Fabregat, G., Asensio‐Samper, J. M., Palmisani, S., Villanueva‐Pérez, V. L., & De Andrés, J. (2013) · Pain Practice · doi:10.1111/j.1533-2500.2012.00569.x · Cited by 35
Metadata
- Authors
- Xiao, L., Mackey, S., Hui, H., Xong, D., Zhang, Q., & Zhang, D.
- Venue
- Pain Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-12
- Volume
- 11
- Issue
- 12
- Pages
- 1827-1833
- ISSN
- 1526-2375 (ISSN-L)
- 1526-4637
- OpenAlex
- W2157433559
- Cited by
- 199
- References
- 29
- FWCI
- 5.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Subcutaneous Injection of Botulinum Toxin A Is Beneficial in Postherpetic Neuralgia. https://app.cochat.ai/papers/10.1111/j.1526-4637.2010.01003.x
- The paper
- Xiao, L., Mackey, S., Hui, H., Xong, D., Zhang, Q., & Zhang, D. (2010). Subcutaneous Injection of Botulinum Toxin A Is Beneficial in Postherpetic Neuralgia. Pain Medicine. https://doi.org/10.1111/j.1526-4637.2010.01003.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.